TABLE 1.
Participant characteristics at baseline
| Variable | Continued (n = 299) | Discontinued (n = 137) | P |
|---|---|---|---|
| Age at V1, y | 41.4 (± 3.5) | 41.4 (±3.4) | 0.857 |
| BMI, kg/m2 | 29.3 (±8.4) | 29.2 (±6.8) | 0.959 |
| Waist circumference, cm | 0.222 | ||
| <80 | 112 (38) | 43 (32) | |
| ≥80 | 179 (62) | 90 (68) | |
| Waist-to-hip ratio | 0.172 | ||
| <0.80 | 133 (46) | 72 (54) | |
| 0.80 to <0.85 | 87 (30) | 29 (22) | |
| ≥0.85 | 70 (24) | 32 (24) | |
| Current smoker | 109 (37) | 56 (41) | 0.420 |
| Race | 0.091 | ||
| African American | 141 (47) | 77 (56) | |
| White | 159 (53) | 59 (43) | |
| No. of children | 0.592 | ||
| 0 | 50 (17) | 18 (13) | |
| 1–3 | 211 (71) | 101 (74) | |
| ≥4 | 35 (12) | 18 (13) | |
| Age at menarche, y | 12.6 (±1.7) | 12.8 (±1.9) | 0.480 |
| Estradiol, pg/mL | 41.1 (28.8) | 50.0 (±55.5) | 0.471 |
| FSH, mIU/mL | 7.8 (±4.5) | 8.6 (±6.1) | 0.204 |
| Inhibin B, ng/mL | 74.7 (47.3) | 78.7 (±47.3) | 0.436 |
Data are mean (±SD) or n (%). Variable n’s vary slightly due to missing data. Menopausal stage not shown because all participants were premenopausal at baseline. BMI, body mass index; FSH, follicle-stimulating hormone.